3. A new @jamaoncology.com paper from ACS Professor @drdawnhershman.bsky.social & colleagues reporting patient-reported fatigue was associated w/ inc'd risk of cancer treatment-related toxic effects. Other ACS-funded authors include Dr. Joe Unger & Dr. Salene Jones. jamanetwork.com/journals/jam...

Baseline Fatigue and Severe Toxic Effects in Patients With Cancer Receiving Systemic Therapy

This cohort study using data from randomized clinical trials evaluates the association of baseline patient-reported fatigue and the risk of toxic effects during subsequent cancer treatment.

jamanetwork.com

Columbia University's economic activity goes far beyond our campuses. Explore our contributions to science, technology, the arts, our city, our nation, and the world, since 1754: https://www.columbia.edu/content/tradition-innovation-and-growth

What is your why? This is mine 🥹

🥰

Dr. Don S Dizon@drdonsdizon.bsky.social · last yr.

I shared the ASCO stage with Dr Dawn Hershman when we were both awarded a career development award as we were starting our careers. Amazing to share the stage with her again as we are awarded once more at #ASCO25. Truly honored and excited to do so.

🙌 proud to be part of this #Dreamteam #PayItForward @conquercancer.bsky.social HSR YIA!!!

@grocquemd.bsky.social · last yr.

Grateful for the opportunity to partner with this cast of characters (missed you Fumiko!) to support an ASCO Young Investigator Award for Health Services Research for next year… and for the excellent party hosted by @conquercancer.bsky.social

Our @swog.org group chair's blog: SWOG at ASCO, 2025 Starting with @drdawnhershman.bsky.social's Karnofsky Science of Oncology Award Lecture in the opening session, the #ASCO25 Annual Meeting will feature some great work by SWOG researchers. www.swog.org/news-events/...

Who From Oncology is Featured in TIME100 Health 2025? @drkarenknudsen.bsky.social @drdawnhershman.bsky.social oncodaily.com/societies/ti... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #TIME100 #Health #TIME100Health

Who From Oncology is Featured in TIME100 Health 2025? - OncoDaily

Discover the key oncology professionals featured in TIME100 Health 2025. and honors the most influential figures shaping cancer treatment.

oncodaily.com

At #ASCO25, @drdawnhershman.bsky.social will be honored with the 2025 David A. Karnofsky Memorial Award for her work in advancing cancer outcomes for all patients. #ASCODailyNews has more on her career & accomplishments: brnw.ch/21wSvbq

Thank you @nytimes.com for highlighting the impact of federal funding cuts on research & patient care. We share a common mission to improve the lives and wellbeing of others, and we share common values that everyone deserves the best care and treatment opportunities. www.nytimes.com/2025/03/18/n...

Trump Cuts Imperil Cancer, Diabetes and Pediatric Research at Columbia

Dozens of medical and scientific studies are ending or at risk of ending, leaving researchers scrambling to find alternative funding.

nytimes.com

I am profoundly grateful for this extraordinary honor 💗

Herbert Irving Comprehensive Cancer Center@columbiacancer.bsky.social · 2y ago

Congratulations to @drdawnhershman.bsky.social, who was recently awarded the David Karnofsky Science of Oncology Award, part of @ascocancer.bsky.social 's 2025 Special Awards which recognizes "tremendous contributions to the oncology community." Read more: connection.asco.org/do/asco-cong...

Incredible accomplishment from our @swog.org 🫁 team. 👏👏👏

Dr. Don S Dizon@drdonsdizon.bsky.social · 2y ago

1/4 @swog.org lung cancer trial, PRAGMATICA, closes early! This randomized trial enrolled 800 volunteers w stage 3-4 lung cancer in 21 months (goal was 700 in 24m). Tested chemo vs ramicirumab/pembrolizumab. Not applicable to every trial, but...

So proud of @minasedrakmd for being recognized as a @SusanGKomen rising star 💫-

Better together- very excited about this @swog.org @alliancenctn.org #CTIU collaboration 🤝

SWOG Cancer Research Network@swog.org · 2y ago

New Trial Alert! The PROSPECT-Lung trial is a new @NCI study looking to improve treatment for patients with #lungcancer. Researchers aim to explore new ways to enhance survival rates & quality of life. Learn more, visit bit.ly/PROSPECTLung #NCI #NCTN #LCsm AllianceNCTN.org @swog.org

The best part of #SABCS24? Lunch with colleagues of course!

Excited to see #PROCTCAE and #GP5 in the inavolisib label! Recurring points in the FDA discussion about needing dose optimization in early drug development to lower doses, maintain efficacy, and improve tolerability. Also comments about needing enrollment of diverse patients. #SABCS24

Super important not to under-treat elderly women - as life expectancy may be quite high!

Tatiana Prowell, MD@tmprowell.bsky.social · 2y ago

#SABCS24 #bcsm #OncSky #SurgSky Dr. R Hills: Meta-analysis of 4 older RCTs of immediate vs deferred surgery in women w/ operable ER+ #breastcancer receiving adjuvant tamoxifen. Immed surgery ⬇️ local progression, distant mets, & BC mortality. NNT <7 to prevent 1 BC death. cc @oncoalert.bsky.social

Thank you all for your advocacy- I would just add - it is not just about measuring pro’s - it’s critically important to mitigate side effects early to help improve tolerance

Kelly Shanahan@stage4kelly.bsky.social · 2y ago

So happy to support my friend @itsnotpink.bsky.social as she brings the @The_Right_Dose patient expert perspective on dose optimization to #SABCS24

Such an important topic - so glad #SABCS24 included this in the program. More work needed to figure out how to include #PRO-cTCAE as an endpoint

Stephanie L. Graff, MD FACP FASCO@drsgraff.bsky.social · 2y ago

Julia Maues @itsnotpink.bsky.social highlights all the ways #TheRightDoseInitiative benefits patients, physicians (shown), and payors—who pay for less sick visits and hospital stays from toxicity. #SABCS24

S2013 and S1501 Reopen for Enrollment with Key Protocol Updates oncodaily.com/insight/200983 @drdawnhershman.bsky.social #Cancer #CancerTreatment #Chemotherapy #SWOG #S2013 #ICIBasedTherapy #ImmuneRelatedAdverseEvents #S1501 #OncoDaily #SWOGNCORPResearchBaseTrials #Oncology

S2013 and S1501 Reopen for Enrollment with Key Protocol Updates - OncoDaily

S2013 and S1501 Reopen for Enrollment with Key Protocol Updates / cancer, cancer treatment, chemotherapy, Dawn Hershman, ICI based therapy, immune related

oncodaily.com

This @swog.org success story is only possible with #NCI federally funded research 🤞

OncoDaily@oncodaily.bsky.social · 2y ago

DART hits the target again - Razelle Kurzrock oncodaily.com/blog/razelle... #Cancer #OncoDaily #Oncology #Medicine #Health

Congrats to Dr. Parminder Singh and Dr. Sonam Puri - recipients of our latest career awards supporting outstanding @swog.org research #SWOGonc cc @moffittnews.bsky.social thehopefoundation.org/blog/general...

Our SWOG Group Chair blog: Modeling Adverse Event Risk Prediction: S2013 and S1501 Are Reopen to Enrollment! Two key trials by the SWOG #NCORP Research Base have reopened after temporary closures. Both trials are prime examples of public-powered research! www.swog.org/news-events/...

#myeloMATCH is the NCI’s #precisionmedicine trial in #myeloid cancer: advanced biomarker testing in newly diagnosed acute myeloid #leukemia (#AML) or #myelodysplastic syndrome (#MDS) & treatment substudies by the Alliance, Canadian Cancer Trials Group, @eaonc.bsky.social & SWOG. swog.org/myeloMATCH

"Because health insurance has become the face of both the rising premiums and the intrusive cost-containment efforts that are largely delegated to them, they have become the primary target of that anger. But it’s not just insurers," Elliott S. Fisher writes: www.statnews.com/2024/12/05/u...

Insurance companies like United Healthcare are not the only ones to blame for a broken system

The public response to United Healthcare CEO Brian Thompson’s murder misunderstands something important.

statnews.com

Congratulations @lynn_hershman for making the Art Review Power 100. 👏👏👏 artreview.com/power-100/

Power 100

artreview.com

The S2312 trial in #mCRPC asks if adding carboplatin to cabazitaxel will significantly improve radiographic PFS in patients whose tumors are aggressive variant #prostatecancer (AVPC-MS) vs those whose tumors are not. PI: Paul Corn, MD, PhD, @mdanderson.bsky.social swog.org/clinical-trials/S2312

That's a wrap! Yesterday marked our final funding deadline of the year. We're busy reviewing, preparing for 2025, and excited for the next big questions we'll help @swog.org members to answer - thank you to our donors who make it all possible! #SWOGonc Upcoming opportunities: tinyurl.com/SWOG2025

Adherence is such big issue and such a challenging problem solve - we found the same thing in breast cancer patients taking endocrine therapy @swog.org study #S1105- pubmed.ncbi.nlm.nih.gov/32369401/ Lots of work needed to improve outcomes in patients who need oral therapies!!

JAMA@jama.com · 2y ago

Text message reminders targeting patients who delay refilling their cardiovascular medications did not improve medication adherence based on pharmacy refill data or reduce clinical events at 12 months. ja.ma/4irtinM

Many patients in the US struggle to afford their prescription drugs. This JAMA Patient Page outlines 7 strategies that patients can use to access medications at reduced cost. https://ja.ma/4g8HcZI